Research Topics
| Anne R MasonSummaryAffiliation: University of York Country: UK Publications
| Collaborators
|
Detail Information
Publications
Is disease management relevant in Europe: some evidence from the United KingdomA Mason
Centre for Health Economics, University of York, Heslington, UK
Health Policy 48:69-77. 1999..The major perceived barrier to an increase in disease management was NHS suspicion of pharmaceutical companies (86% of all respondents), with the difficulty in drawing up contracts coming a close second (79%)...- The effectiveness and cost-effectiveness of respite for caregivers of frail older peopleAnne Mason
Centre for Health Economics, University of York, York, United Kingdom
J Am Geriatr Soc 55:290-9. 2007..Given the increasing numbers of frail elderly people and the lack of up-to-date, good-quality evidence for all types of respite care, better-quality evidence is urgently needed to inform current policy and practice... 
Public funding of new cancer drugs: Is NICE getting nastier?Anne R Mason
Centre for Health Economics, Alcuin A Block, University of York, Heslington, York YO105DD, UK
Eur J Cancer 45:1188-92. 2009..The National Institute for Health and Clinical Excellence (NICE) assesses clinical and cost-effectiveness, but recent restrictions on the availability of cancer drugs suggest that NICE may be getting tougher...- Publishing outcome data: is it an effective approach?Anne Mason
Centre for Health Economics, Alcuin Block A, University of York, York, UK
J Eval Clin Pract 12:37-48. 2006..In theory, publication may help to promote public trust, support patient choice, and stimulate action to improve the quality of care whilst controlling costs... 
Does the English NHS have a 'Health Benefit Basket'?Anne Mason
Centre for Health Economics, University of York, UK
Eur J Health Econ . 2005..Regulation may, however, be important in determining citizens' rights. With reference to 'services of curative care', this paper explores whether the NHS is moving towards a more explicit definition of a health basket...- Prescribing incentive schemes : a useful approach?Anne R Mason
Centre for Health Economics, University of York, Heslington, York, England
Appl Health Econ Health Policy 4:111-7. 2005..Our objective was to explore whether schemes might be a useful approach to encourage 'good quality' prescribing... - Should prospective payments be differentiated for public and private healthcare providers?Anne Mason
Centre for Health Economics, University of York, York YO10 5DD, UK
Health Econ Policy Law 4:383-403. 2009..However, differences in capital costs appear less tractable and further investigation into possible solutions is warranted... - Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?Anne Mason
Centre for Health Economics, University of York, York, United Kingdom
J Clin Oncol 28:3234-8. 2010..Coverage decisions that consider cost effectiveness may lead to restrictions in access... - Support services for carers of people with mental health problems: building an evidence base to inform policy decisionsAnne Mason
Centre for Health Economics, University of York, Heslington, York YO10 5DD, UK
Appl Health Econ Health Policy 2:37-42. 2003..This paper elucidates issues arising from the study and explores ways towards a more evidence-based future... - Optometrist prescribing of therapeutic agents: findings of the AESOP surveyAnne Mason
Centre for Health Economics, University of York, Heslington, UK
Health Policy 60:185-97. 2002..However, adequate comparative research on the performance of optometrists as prescribers is needed and the issue of reimbursement will require careful consideration... - New medicines in primary care: a review of influences on general practitioner prescribingA Mason
Centre for Health Economics, University of York, Heslington, York, UK
J Clin Pharm Ther 33:1-10. 2008..Focussing on new medicines, this review aimed to explore the determinants of uptake, the causes of geographical variations, and the influence of price, cost and financial incentives on prescribing behaviour... - European perspective on the costs and cost-effectiveness of cancer therapiesMichael F Drummond
Centre for Health Economics, University of York, York, United Kingdom
J Clin Oncol 25:191-5. 2007.... - Value for money and the Quality and Outcomes Framework in primary care in the UK NHSSimon Walker
Centre for Health Economics, University of York, Heslington, York, UK
Br J Gen Pract 60:e213-20. 2010..Despite its achievements, there are concerns that the QOF may offer poor value for money... - Topical treatments for chronic plaque psoriasisAnne R Mason
Centre for Health Economics, The University of York, York, UK
Cochrane Database Syst Rev 3:CD005028. 2013..First-line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid, and topical retinoids... - A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carersA Mason
Centre for Health Economics, University of York, UK
Health Technol Assess 11:1-157, iii. 2007..Where data permitted, subgroups of carers and care recipients, for whom respite care is particularly effective or cost-effective, were to be identified... - Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluationJ Wilby
Centre for Reviews and Dissemination, University of York, UK
Health Technol Assess 9:1-157, iii-iv. 2005..Future RCTs should use CONSORT guidelines; and observational data to provide information on the use of AEDs in actual practice, including details of treatment sequences and doses... - Medication management in English National Health Service hospitalsJonathan Cooke
Withington Hospital, South Manchester University Hospitals NHS Trust, Nell Lane, West Didsbury, Manchester M20 2LR, United Kingdom
Am J Health Syst Pharm 62:189-95. 2005..The methods currently used by English National Health Service (NHS) hospitals to manage the use of medicines were studied...